For the quarter ended March 2025, Cardinal Health (CAH) reported revenue of $54.88 billion, down 0.1% over the same period last year. EPS came in at $2.35, compared to $2.08 in the year-ago quarter.
The reported revenue represents a surprise of -0.27% over the Zacks Consensus Estimate of $55.03 billion. With the consensus EPS estimate being $2.15, the EPS surprise was +9.30%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Cardinal performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Pharmaceutical and Specialty Solutions: $50.43 billion versus the four-analyst average estimate of $50.33 billion. The reported number represents a year-over-year change of -0.4%.
- Revenue- Other: $1.30 billion versus $1.29 billion estimated by four analysts on average.
- Revenue- Medical Products and Distribution: $3.16 billion versus the four-analyst average estimate of $3.21 billion. The reported number represents a year-over-year change of +1.5%.
- Segment profit- Pharmaceutical and Specialty Solutions: $662 million versus $635.77 million estimated by four analysts on average.
- Segment profit- Other: $134 million versus $119.24 million estimated by four analysts on average.
- Segment profit- Global Medical Products and Distribution: $39 million compared to the $44.16 million average estimate based on four analysts.
View all Key Company Metrics for Cardinal here>>>
Shares of Cardinal have returned +1.9% over the past month versus the Zacks S&P 500 composite's -0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
